Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 20,000 | 0 | 2,234 | 4,310 | 0 |
| Gross Profit | 20,000 | N/A | 2,234 | 4,310 | N/A |
| Operating Expenses | 11,041 | -63,112 | 27,633 | 59,531 | 14,627 |
| Operating Income | 8,959 | 63,112 | -25,399 | -55,221 | -14,627 |
| Other Income | -15 | 1 | -43 | -3 | -69 |
| Pre-tax Income | 8,944 | 63,113 | -25,442 | -55,224 | -14,696 |
| Income Tax | 0 | -8,561 | N/A | 288 | 313 |
| Net Income Continuous | 8,944 | 71,674 | -25,442 | -55,512 | -15,009 |
| Net Income | $8,944 | $71,674 | $-25,442 | $-55,512 | $-15,009 |
| EPS Basic Total Ops | 2.76 | 7.20 | -3.00 | -7.00 | -1.40 |
| EPS Basic Continuous Ops | 2.65 | 7.28 | -2.90 | -7.07 | -2.84 |
| EPS Diluted Total Ops | 2.76 | 7.20 | -3.00 | -7.00 | -1.40 |
| EPS Diluted Continuous Ops | 2.80 | 7.13 | -2.90 | -7.07 | -2.84 |
| EBITDA(a) | $8,970 | $94,822 | $-25,365 | $-55,191 | $-14,597 |